Many (if not all) of those BP's listed by aragon (and others in the past) could, if sufficiently interested, move to acquire IPIX. Would any such interest be sufficient to convince IPIX management. Who knows? Many could also be interested in partnering/licensing for one or multiple indications. No one will know how it initially shakes out until it is announced. Could be any time now.